Sign in
4

Changes in Ownership

INTEGRATED BIOPHARMA INC Filed Acc 0001016504-04-000002

Chief Financial Officer sold 3,000 shares at an average $12.82 ($38,465)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FRIEDMAN ERIC J Chief Financial Officer 2004-01-08 Sale −300 $12.90 $3,870 74,700 D: show line 1 in the form
FRIEDMAN ERIC J Chief Financial Officer 2004-01-08 Sale −500 $12.87 $6,435 74,200 D: show line 2 in the form
FRIEDMAN ERIC J Chief Financial Officer 2004-01-08 Sale −2,200 $12.80 $28,160 72,000 D: show line 3 in the form
Open-market sales · 3,000 sh · avg $12.82 · $38,465

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
FRIEDMAN ERIC J Chief Financial Officer 1996-10-16 Other disposition · Stock Options (Right to Buy) −0 100,000 D: show line 4 in the form
FRIEDMAN ERIC J Chief Financial Officer 1998-10-07 Other disposition · Stock Options (Right to Buy) −0 66,666 D: show line 5 in the form
FRIEDMAN ERIC J Chief Financial Officer 1999-12-01 Other disposition · Stock Options (Right to Buy) −0 150,000 D: show line 6 in the form
FRIEDMAN ERIC J Chief Financial Officer 2000-12-19 Other disposition · Stock Options (Right to Buy) −0 100,000 D: show line 7 in the form
FRIEDMAN ERIC J Chief Financial Officer 2002-10-11 Other disposition · Stock Options (Right to Buy) −0 75,000 D: show line 8 in the form
Loading xslF345X02/inbf4jan9_2003ex.xml…